N3 Alkylated Benzimidazole Derivative As Mek Inhibitor
Patent No. EP3000810 (titled "N3 Alkylated Benzimidazole Derivative As Mek Inhibitor") was filed by Array Biopharma on Mar 13, 2003. The application was issued on Jul 19, 2017.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3000810
- Application Number
- EP15177189A
- Filing Date
- Mar 13, 2003
- Status
- Revoked
- May 24, 2019
- Publication Date
- Jul 19, 2017
- External Links
- Slate, Register , Google Patents